AI-generated summary
In this preclinical mouse study, the authors report that transcranial pretreatment with a low-power 1064-nm near-infrared laser before a simulated stroke improved cerebral blood flow, eNOS phosphorylation and stroke outcomes. The authors describe the findings as proof-of-concept and suggest the approach could be an adjunctive therapy, though it has not been tested in humans.
- Who or what was studied
- Mice (ischemic stroke model, including eNOS S1176A knock-in mice)
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The study is a preclinical mouse proof-of-concept study, so the findings may not apply to patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ahajournals.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power density (irradiance)
- 50 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Stroke, Near-infrared, Photobiomodulation, Laser, Nitric oxide, Cerebral blood flow, Irradiance. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.